Cite
HARVARD Citation
Broman, N. et al. (2022). 'Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM' – Author's reply. Clinical microbiology and infection. pp. 1520-1521. [Online].